We review the Edelweiss Healthcare Index fund NFO, which is open for subscription from the 6th of October to the 20th of October. The Edelweiss MSCI India Domestic & Global Healthcare 45 Index Fund is a passive fund and will follow the MSCI India Domestic and world healthcare index. This index comprises of 45 stocks, of which 25 companies are listed in India, while the remaining 20 are global companies listed on the US stock exchanges. In terms of assets, 70% of the assets will be proportioned to the Indian companies. This will include top companies in terms of market cap from various sub-sectors, such as pharma, hospitals, diagnostics, life sciences and biotech. The balance 30% will be allocated to the global companies, which would include top 5 from 4 sub-sectors, i.e., pharma, healthcare equipment, biotechnology, and life sciences. The healthcare spending in India is still low. It is expected that the money allocated to R&D and healthcare infrastructure will increase substantially in the next few years, especially given the situation due to the covid-19 pandemic. This creates a big opportunity for the sector. Investors with a diversified portfolio could consider investing in this Edelweiss MSCI Index fund.